(NYSE:AET) Stake Decreased by Acadian Asset Management LLC

Institutional investors own 91.73% of the company’s stock.

Aetna Inc. (AET) stock exposed a turn of -3.86% in most recent week and accomplished -1.41% performance over the last one month.

Several other institutional investors have also recently bought and sold shares of AET. New York-based Spirit Of America Management Corporation has invested 0.05% in Aetna Inc (NYSE:AET). Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. Berkshire Asset Management LLC PA boosted its stake in shares of Aetna by 3.5% in the second quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares in the last quarter. Rehmann Capital Advisory Group boosted its position in Aetna by 1.1% in the first quarter. HL Financial Services LLC boosted its position in shares of Aetna by 2.0% in the second quarter. NN Investment Partners Holdings N.V. now owns 687,675 shares of the company’s stock valued at $87,713,000 after buying an additional 491,855 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. boosted its position in shares of Aetna by 251.2% in the first quarter. The Css Llc holds 11,573 shares with $973,000 value, down from 34,700 last quarter. Federated Pa holds 0.04% in Aetna Inc (NYSE:AET) or 106,979 shares. The stock of Aetna Inc (NYSE:AET) has “Hold” rating given on Wednesday, August 5 by Oppenheimer. The company had a trading volume of 929,296 shares.

It is now trading at $152.42 which is marginally under $154.28, the 50 day moving average and a great deal higher than the 200 day moving average of $138.79. More interesting news about Aetna Inc (NYSE:AET) were released by: Reuters.com and their article: “Health insurer Aetna profit rises as Obamacare business shrinks” published on August 03, 2017 as well as Nasdaq.com’s news article titled: “Aetna Inc Announces 47% Advance In Q2 Bottom Line” with publication date: August 03, 2017.

Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. RBC Capital Markets maintained Aetna Inc (NYSE:AET) rating on Tuesday, February 2. Aetna’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 EPS. Analysts expect next quarter’s EPS will be $1.38 with next year’s EPS anticipated to be $10.14.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors with a record date on Early Thur, Jul 13th were issued a divided of $0.50 for a share. this indicates a $2.00 dividend on a yearly basis and a payout of of 1.29%. The stock declined 1.44% or $2.24 reaching $153.34 per share. The ex-dividend date was Tue, Jul 11th.

Valuation Ratios of Aetna Inc.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by Community Financial News and is owned by of Community Financial News. The value of the investment in AET went from $556,000 to $617,000 a change of $61,000 for the reporting period. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of USA and global copyright law. The original version of this story can be read at https://stocknewstimes.com/2017/08/11/bp-plc-continues-to-hold-stake-in-aetna-inc-aet.html.

A number of research firms recently weighed in on AET. UBS AG restated a “buy” rating and set a $160.00 price target (up previously from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Deutsche Bank AG raised their price target on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday.

Among 21 analysts covering Aetna (NYSE:AET), 11 have Buy rating, 0 Sell and 10 Hold.

Among 21 analysts covering Aetna (NYSE:AET), 11 have Buy rating, 0 Sell and 10 Hold. Aetna has an average rating of “Buy” and an average target price of $157.09. Bertolini Mark T sold $14.58M worth of stock or 103,547 shares. SOISTMAN FRANCIS S JR sold $872,020 worth of stock or 6,607 shares. Following the completion of the transaction, the chairman now directly owns 659,888 shares in the company, valued at $92,905,631.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 20,000 shares were sold by Matthew Price, worth $1.82M on Wednesday, February 15. After this trade, the EVP has an ownership of 33,563 stocks in the company, worth at $5,008,606.49. corporate executives has an ownership of 0.90% of the firms stock.